Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Net Income towards Common Stockholders (2017 - 2020)

enVVeno Medical has reported Net Income towards Common Stockholders over the past 4 years, most recently at -$5.0 million for Q4 2020.

  • Quarterly results put Net Income towards Common Stockholders at -$5.0 million for Q4 2020, down 116.41% from a year ago — trailing twelve months through Dec 2020 was -$10.0 million (down 31.28% YoY), and the annual figure for FY2025 was -$20.2 million, up 13.78%.
  • Net Income towards Common Stockholders for Q4 2020 was -$5.0 million at enVVeno Medical, down from -$2.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for NVNO hit a ceiling of -$1.4 million in Q2 2017 and a floor of -$8.2 million in Q2 2018.
  • Median Net Income towards Common Stockholders over the past 4 years was -$1.9 million (2019), compared with a mean of -$2.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 503.68% in 2018 and later surged 76.34% in 2019.
  • enVVeno Medical's Net Income towards Common Stockholders stood at -$3.3 million in 2017, then skyrocketed by 45.22% to -$1.8 million in 2018, then dropped by 28.58% to -$2.3 million in 2019, then plummeted by 116.41% to -$5.0 million in 2020.
  • The last three reported values for Net Income towards Common Stockholders were -$5.0 million (Q4 2020), -$2.0 million (Q3 2020), and -$1.5 million (Q2 2020) per Business Quant data.